- Home
- CHRS vs GAME Comparison
CHRS vs GAME Comparison
Compare CHRS & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- GAME
- Stock Information
- Founded
- CHRS 2010
- GAME 2011
- Country
- CHRS United States
- GAME United States
- Employees
- CHRS N/A
- GAME N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- GAME
- Sector
- CHRS Health Care
- GAME
- Exchange
- CHRS Nasdaq
- GAME Nasdaq
- Market Cap
- CHRS 102.0M
- GAME 97.9M
- IPO Year
- CHRS 2014
- GAME 2009
- Fundamental
- Price
- CHRS $1.05
- GAME $0.77
- Analyst Decision
- CHRS Buy
- GAME Strong Buy
- Analyst Count
- CHRS 3
- GAME 3
- Target Price
- CHRS $4.68
- GAME $3.67
- AVG Volume (30 Days)
- CHRS 1.5M
- GAME 10.4M
- Earning Date
- CHRS 08-07-2025
- GAME 08-14-2025
- Dividend Yield
- CHRS N/A
- GAME N/A
- EPS Growth
- CHRS N/A
- GAME N/A
- EPS
- CHRS 1.55
- GAME N/A
- Revenue
- CHRS $272,209,000.00
- GAME $93,375,339.00
- Revenue This Year
- CHRS N/A
- GAME $6.08
- Revenue Next Year
- CHRS $142.61
- GAME $21.94
- P/E Ratio
- CHRS $2.05
- GAME N/A
- Revenue Growth
- CHRS 52.33
- GAME 54.19
- 52 Week Low
- CHRS $0.66
- GAME $0.50
- 52 Week High
- CHRS $2.43
- GAME $2.87
- Technical
- Relative Strength Index (RSI)
- CHRS 62.88
- GAME 38.45
- Support Level
- CHRS $0.81
- GAME $0.89
- Resistance Level
- CHRS $0.95
- GAME $1.09
- Average True Range (ATR)
- CHRS 0.07
- GAME 0.11
- MACD
- CHRS 0.01
- GAME -0.02
- Stochastic Oscillator
- CHRS 85.71
- GAME 5.45
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.